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ABSTRACT 
PEDIATRIC PATIENTS WITH DIABETES TRANSITION TO 
ADULT CARE  
The purpose of this study was to identify the optimal age to target transition 
to adult care education for adolescent and young adults (AYA) with Type 1 and 
Type 2 Diabetes Mellitus (DM) as they transition from pediatric endocrinology 
providers to adult DM providers. A secondary purpose of this study was to 
identify if there was a relationship between attendance rate, age, gender, years 
diagnosed with DM, ethnicity, insurance type, Type of DM, and current county of 
residence with control of diabetes, measured by glycosylated hemoglobin 
(HgbA1c). A quantitative study through chart audits was conducted at Valley 
Children’s Healthcare, VCH, pediatric endocrinology practice, in Madera, 
California. Patients with the diagnosis of Type 1 or Type 2 DM born been 1997- 
1999, aged eighteen to twenty-one years old seen for at least one provider visit in 
2017, were audited.  The data was analyzed for Chi-Square Test of Independence 
to identify if attendance rate to appointments between 2014-2017 has a 
relationship to patients year of birth and to determine if the average HgbA1c in 
2017 has a relationship to patient demographics.   
The research instrument was an excel work sheet used to analyze collected 
data. Data was collected by manual chart audits and analyzed with SPSS soft 
wear.  
Current literature lacks conclusive data of when transition to adult care 
skills should be taught to AYAs with DM and how it impacts diabetic control in 
adolescents and young adults with DM.  In addition, unique factors that have not 
been previously studied in the population seen at VCH are that eighty percent of 
patients have Medi-Cal California Children Services insurance indicating the 
majority of the population lives below the federal poverty level; the practice is a 
regional center for over twelve counties in California; and sixty-five percent of 
children in this region are from Hispanic origin.   
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CHAPTER 1: INTRODUCTION 
 The American Academy of Pediatrics gave a consensus opinion that 
pediatric healthcare providers should empower adolescents to transition to adult 
care through the development of formalized transitional programs (2011). For 
pediatric patients with diabetes, with either type 1 or type 2 Diabetes Mellitus 
(DM), transitioning to adult care can present considerable challenges to accessing 
care and effectively self-managing DM.  In the United States, high rates of DM are 
resulting in close to a million diagnosed patients with DM younger than eighteen 
years old, who will be transitioning to adult care at a rate of tens of thousands per 
year (Peters, Laffel, & American Diabetes Association Transitions Working 
Group, 2011). Barriers to transitioning to adult care can result in short and long-
term health complications for AYA patients with DM.  
Peters et al. (2011) found barriers to transitioning to adult care include lack 
of empirical evidence for the transition process and determining the readiness for 
transition, essential differences in how pediatric and adult health care is provided, 
developmental and social changes in young adulthood, gaps and changes in health 
insurance during this transitional age, unique learning style and requirements of 
this age group, and a lack of trained adult healthcare providers to assume care for 
this population as they transition to adulthood.  These barriers to transitioning to 
adult care frequently result in poor health indicators for this population.  Poorly 
controlled DM is associated with chronic microvascular and macrovascular 
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complications that may develop into renal and cardiovascular disease, and 
increased risk of acute complications from high and low blood sugars.   
The lack of a formal transitional program, to aid patients to overcome 
barriers to care, for pediatric patients with DM transitioning to adult care, is 
directly related to poor health outcomes for this population. The purpose of formal 
transitional programs is to optimize the lifelong functioning and quality of life for 
AYAs by ensuring appropriate medical and developmental care is provided to 
each patient at every age (American Academy of Pediatrics, 2011). Barriers for 
pediatric patients with DM transitioning to adult care include lack of empirical 
evidence to determine readiness for transition (Peters et al., 2011).  Research of 
AYAs with DM transitioning to adult care has revealed opportunities and gaps in 
research about when pediatric patients with DM should be transitioned to adult 
care.  
The purpose of this Doctor of Nursing Practice (DNP) project and study 
was to identify if there is an optimal age to target transition to adult care education 
for AYAs with DM as that transition from pediatric endocrinology providers to 
adult DM providers. A secondary purpose of this study was to identify if there is a 
relationship between specific demographic categories and control of DM in AYAs 
seen at Valley Children’s Healthcare’s pediatric endocrinology practice (VCH). 
Current literature lacks conclusive data of when transition to adult care 
skills should be taught to AYAs with DM and how this may impact diabetic 
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control in AYAs with DM.  In addition, unique factors that have not been 
previously studied in the population seen at VCH are that eighty percent of 
patients have Medi-Cal California Children Services insurance indicating this 
population is below the federal poverty level, the practice is a regional center for 
over twelve counties in California, includes research on AYAs with Type 2 DM, 
and sixty-five percent of children in this region are Hispanic (Lucile Packard 
Foundation, 2018).   
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CHAPTER 2: LITERATURE REVIEW 
Zoni et al. (2018) led a mixed method, descriptive and cross-sectional 
study, of young adult Type 1 DM patient’s perception of nurse-led transition 
programs from pediatric to adult diabetes care. The sample consisted of twenty 
patients who agreed to participate out of the fifty-eight patients who participated in 
the pilot program.  The sample consisted of patients with Type 1 DM who were 
aged sixteen to twenty-five years old.  Race, ethnicity, and socioeconomic status 
were not reported.  The sample consisted of thirteen females and seven males. The 
setting was at a pediatric endocrinology practice at the University Hospital of 
Lusanne, Switzerland.  The research method included collecting glycated 
Hemoglobin levels (HgbA1c) and a questionnaire.  The questionnaire included the 
assessment of Self-Care Inventory (SCI) and Caring Nurse-Patient Interactive 
Short Scale to assess the self-management and therapeutic relationship.   The data 
was reported with descriptive statistics.  Pearson product moment coefficients of 
correlation and calculations of frequency were used to identify relationships 
between self-care, age, and gender. Analysis was done with STATA13.  Outcomes 
included that the sample was compliant with insulin injections, but had poor 
adherence with diet, and overall satisfaction score of four out of five score with 
nurse-led visits.  Privacy was the most important issue with the sample. The 
researchers concluded that nurse-led visits for young adults with Type 1 DM was a 
valid and important partner to medical management in the transition to adult care.  
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The strength of this study is that the pilot program successfully used a nurse-led 
program with a nursing care model.  A weakness of the study is there is no 
consensus within the field to evaluate transition outcomes.  
Garvey et al. (2017) conducted a quantitative study to evaluate transition 
experiences in young adults with Type 1 DM before and after they transitioned 
from pediatric to adult care. The researchers sent an electronic survey to eighteen 
to twenty-nine year-olds through sixty Type 1 DM exchange clinic registry 
centers. The sample consisted of six-hundred and two participants, with three-
hundred and three in the PEDS, prior to transition, and two-hundred and ninety-
nine in the ADULT, after transition, groups. The average age was twenty-two 
years old in the PEDS group and nineteen years old in the ADULT group.  
Demographic data was requested from Type 1 DM registry centers, but not 
reported in this study.  The electronic survey included transition experience 
survey, SCI, Problem Areas in Diabetes (PAID), and self-report of most recent 
HgbA1c. Descriptive analysis was done for transition reasons and experience. 
Self-reported HgbA1c, age of transition, and anticipated age of transition were 
analyzed with a t-test.  Gender and reproductive health education were analyzed 
with a X2 test.  Relationships between HgbA1c <7%, transition education, and 
readiness to transition were analyzed with a multivariable logistic regression with 
a stepwise procedure in both groups. SCI and PAID scores were analyzed with a 
multivariable linear regression model. The researchers found that the ADULT 
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group had less visits prior to transition and felt unready to transition and were the 
most likely to have a six month or more gap in care between pediatric and adult 
health care provider. A majority of the sample, 80%, were initially treated by a 
pediatric endocrinologist but only 43% of PEDS group and 33% of ADULT group 
were educated on reproductive health related to Type 1 DM.  In addition, only 
50% of PEDS and 66% of ADULT group had transition to adult care issues 
reviewed in a provider visit.  The researchers identified visits focused on transition 
issues may decrease gaps in care at transition to adult care. A limitation of this 
study is while the researchers requested a HgbA1c level within the past six months 
from the registry clinic, many patients had not attended a visit within six months, 
therefore the researchers used self-reported HgbA1c for analysis. The strength of 
this study is the large sample including multiple centers of care.  
Pierce et al. (2017) conducted a qualitative direct content analysis of 
telephone interviews with stakeholders to identify outcomes of young adults with 
Type 1 DM during Health Care Transition, HTC, to adult care. The sample of 
forty-six included parents, patients, pediatric and adult healthcare providers, and 
experts in HCT.  The sample was selected from and interviewed via telephone 
with patients and providers in the Delaware Valley Health Systems in North and 
Central Florida.  Demographics were not reported.  The interviews used semi-
structured and open-ended questions. The data was analyzed using a priori coding 
scheme for fit with the SMART expanded model.  The researchers identified 
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HgbA1c, ability to navigate healthcare systems, integration of self-care into adult 
roles, autonomy with family involvement, and self-care accountability as themes 
of outcome goals. The researchers concluded that providers could use the SMART 
expanded model to help assess readiness to transition and measurable outcomes of 
success to transition.  A weakness of this study is that participants had to be fluent 
in English to be included in the sample. A strength of this study is that it included 
parents, patients, and providers in the sample.  
Pyatak et al. (2017) conducted a mixed methods analysis with three groups 
including last year of care, lost to follow up, and a control group to identify and 
treat Type 1 DM patients who were lost to follow-up during transition from 
pediatric to adult care.  The sample included fifty-four pediatric patients in their 
last year of care, CC group, and twenty-four patients lost to follow up in transition 
to adult care, LC group. The CC group was on average nineteen years old, 49% 
female 51% male, 64% Hispanic, 10% white, and 10% black.  The LC group was 
an average of twenty-one years old, 41% female, 59% male, 70% Hispanic, 25% 
white, and 5% black. This study was part of the Helmsley T1D study and was part 
of the Let’s Empower and Prepare program at the University of Southern 
California. Data was collected via medical records and patients were prospectively 
followed for one year. Patients were given diabetes education, a case manager, and 
a structured transition program. The researchers used SAS for windows to conduct 
paired t-tests to compare clinical, psychosocial, and follow-up care utilization 
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between the CC and LC groups. The findings included that the LC group had an 
average of 11.6 months in gap in care at transition to adult care.  The CC group 
had no gap.  The LC group had higher HgbA1c, depressed symptoms, were more 
likely to be lost to follow up care, and had more Emergency Room visits for low 
blood sugars.  Both groups had improved HgbA1c after enrollment in the 
transition program. A weakness of this study is that the control group was not 
reported in the results.  A strength of this study is that the researchers 
demonstrated positive patient outcomes with the Let’s Empower and Prepare 
program.  
 Agarwal et al. (2017) evaluated a model of adult endocrinologist led 
transition care for young adults with Type 1 DM through a quantitative study.  The 
University of Pennsylvania studied a cohort of seventy-two young adults with 
Type 1 DM aged eighteen to twenty-five years old who were transitioned between 
Children’s Hospital of Philadelphia and University of Pennsylvania.  The sample 
was 50% female, 50% male, 62% Caucasian, 25% African American, 2% 
Hispanic, with 50% using public insurance. The sample was given a pre and post 
program assessment with a six month mean daily blood glucose frequency and 
HgbA1c compared pre and post program.  Data was collected from medical 
records. The cohort participated in a transition clinic led by Registered Nurses, 
Nurse Practitioners, Diabetic Educators, Social Workers, and Endocrinologists 
who provide care to adults.  Multiple linear regression and paired t-tests were used 
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to analyze the data with STATA 14.0 for Windows.  The researchers found that on 
average HgbA1c decreased by 0.7% and BG testing increased by one time per day 
post program.  In addition, 88% of patients attended two or more visits in the six 
months they participated in the transition program. A weakness of this study is that 
a large part of the cohort was lost to follow-up.  One-hundred and twenty-two 
patients were referred to the program, seventy-two attended an appointment and 
joined the cohort.  The researchers identified that the patients lost to follow-up 
may have moved or experienced a gap in care.  A strength of this study is that it 
was the first to measure frequency of Blood Glucose testing as an outcome 
measure.  
Kiziler, Yidiz, and Fidanci (2018) wanted to validate the Turkish version of 
Transition Readiness Assessment Questionnaire for AYAs with DM transitioning 
to adult care using a methodological study.  The participants were given the 
Turkish Transition Readiness Assessment Questionnaire and a self-care scale 
through in-person interviews at two different pediatric endocrinology practices in 
Turkey. The questions included self-assessment of taking medications, attending 
appointments, talking to providers, and activities of daily living.  The sample 
consisted of one-hundred and nine patients with Type 1 DM aged fourteen to 
twenty-two years old. The participants were Turkish and had to have DM for at 
least one year to be included in the study. The sample was 53.2% male, average 
age was fifteen years old, mean age at diagnosis of Type 1 DM was ten years old, 
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and average duration of having Type 1 DM was 4.8 years. The data was analyzed 
for frequency using descriptive statics, Pearson’s correlation, and analyzed with 
SPSS software.  The researchers found that 56% of patients did not consistently 
record blood glucose, 52% took their medications without being instructed to by 
family members, 82.6% denied differences in their activities of daily living 
compared to peers, and 26% contacted their providers without family involvement.  
The researchers concluded that the reliability of the questionnaire was valid with a 
p value of <0.05.  A weakness of the study is that it has not been repeated by other 
researchers to validate the results.  A strength of this study is the large sample size 
and the validation of the Readiness Assessment Questionnaire in Turkish culture 
and language.  
Kime (2013) evaluated the effectiveness of adolescents’ transition to adult 
care using process mapping methodology.  Kime (2013) used data from the “Join 
Us on our Journey” study from the National Health Service in the United 
Kingdom collected over three years from nine regions and three-hundred 
participants.  Specific demographics about the population were not included in the 
article. The researchers collected data in group sessions and data was analyzed for 
themes.  Themes included a focus on transferring responsibility to adult providers 
and not the overall wellbeing on the patient, lack of consistency in the transition 
process, a lack of communication from providers to families and adult providers 
about the transition, and patients felt the transition process should take at least two 
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years.  A strength of the study in the large sample of three-hundred participants, 
while a weakness is a lack of specific demographics about the population.  
Gaps in the Literature 
This literature review identified gaps and strengths in the care of pediatric 
patients transitioning to adult care. Zoni et al. (2018) identified more research is 
needed to identify best practices for transitional care programs, but nurse-led 
programs are a valid tool to support transition. Garvey et al. (2017) recognized 
there is a need for development and evaluation of standardized transitional 
education tools and that pediatric endocrinology visits focused on transitional 
issues may decrease gaps in care at transition to adult care. Pierce et al. (2017) 
focused on the need to develop measurable outcome tools to enable benchmarking 
between practices. Pierce et al. (2017) suggest that HgbA1c, healthcare navigation 
skills, integration of self-care into adult roles, balancing parent involvement with 
autonomy, and accountability in self-care should be the focus of outcomes. 
Kiziler, Yidiz, and Fidanci (2018) found the Readiness Assessment Questionnaire 
to be valid in Turkish culture and language but need the study to be repeated to 
confirm validity. Kime (2013) found that current practices fail to be  
holistic or patient centered, and patients would recommend the transition process 
take at least two years. 
Agarwal et al. (2017) and Pierce et al. (2017) both used the SMART model 
as their conceptual framework.  Zoni et al. (2018) and Garvey et al (2017) both 
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used SCI to assess their sample. Pierce et al. (2017) and Kiziler et al. (2018) found 
that self-care is a vital outcome of transition clinics. Agarwal et al. (2017) 
identified that adult endocrinologist may be able to lead successful transition 
programs. More research including randomized to program versus control groups 
is needed to validate their findings.  Pyatak et al. (2017) identified that formal 
transition programs can decrease Emergency Room visits and HgbA1c in this 
population. Pyatak et al. (2017) also identified that there is a need for more tools 
and interventions for psychosocial needs of young adults with Type 1 DM. 
Pediatric patients transitioning to adult care benefit from formalized programs, but 
there is a lack of formalized and standardized tools to measure readiness and 
outcomes.  The literature review demonstrates a gap in research and empirical 
evidence related to when the transitional process should start, how to assess 
readiness to transition, how long the transition process should take, and how to 
measure if a transition has been successful. 
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CHAPTER 3: METHODOLOGY 
 Current literature lacks conclusive data of when transition to adult care skill 
should be taught to AYAs with DM and how this impact’s diabetic control in 
AYAs with DM.  The purpose of this study was to identify the optimal age to 
target transition to adult care education for AYAs with Type 1 and Type 2 DM as 
they transition from pediatric endocrinology providers to adult DM providers.  A 
secondary purpose of this study was to identify if there was a relationship between 
demographics including attendance rate, age, gender, ethnicity, insurance type, 
Type 1, Type 2 DM, and current county of residence with control of DM, 
measured by HgbA1c for this population.    
Sample, Setting, and Data Collection 
The sample size was two-hundred and twenty six patients seen at VCH in 
2017.  Inclusion criteria was being seen at VCH, born between 1997-1999 (age 
eighteen to twenty-one years old in 2017),  with at least one provider (defined as 
with a visit with a Medical Doctor or Nurse Practitioner) visit in 2017, diagnosed 
with DM prior to 2017, and billed under the ICD 10- billing codes: E10.65, E10.9, 
E11.65, E11.9 (Type 1 or Type 2 DM).  All other patients seen at the practice were 
excluded from the study. No special groups were included in this study.  
A retrospective manual chart audit was done at VCH. Due to this, no 
recruitment was done. The procedure  for this study was a manual chart audit of 
historical records.  Special procedures included the principal investigator manually 
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auditing patient’s charts in Athena, the electronic medical record system at VCH.  
Information collected included age, gender, ethnicity, insurance type, type of DM, 
current county of residence, visit attendance between 2014-2017, and lab results 
for HgbA1c for each subject of the study. Front office staff entered demographic 
information, scheduled patient visits, while medical assistants entered lab results, 
which were all verified by the provider in the practice during the visit in the 
Athena medical record system that was audited.  Providers in the practice were 
either a Nurse Practitioner or Medical Doctor.  Data was entered in the researchers 
data collection tool, an excel worksheet (See Appendix A-DNP Data Instrument). 
Data was coded and entered into the DNP data tool as it was collected (See 
Appendix B-DNP Coding Key) VCH Heath Insurance Portability and 
Accountability Act (HIPAA) and Protected Heath Information (PHI) policy and 
procedures were followed at all times to protect patient privacy and maintain 
minimal risk during the study (see Appendix C-VCH HC-0020 and HC-0021). 
Each audit for each subject was done once and took about five minutes to 
complete.  The chart audit was done on a VCH password protected computer 
assigned to the principal researcher. 
Data Analysis and Hypotheses 
Contingency tables were generated from the DNP Data Instrument, 
Microsoft Excel worksheet (see Appendix D-DNP Data with Contingency Tables) 
and analyzed for descriptive statistics by SPSS software.  The first hypothesis was 
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analyzed with Chi-Square Test of Independence. Null Hypothesis: The attendance 
rate to appointments between 2014-2017 did not have a relationship to patient’s 
year of birth.  Alternative Hypothesis: The attendance rate to appointments 
between 2014-2017 had a relationship with patient’s year of birth. 
 The second hypothesis was also analyzed with Chi-Square Test of 
Independence using SPSS software.  Null Hypothesis: The average HgbA1c in 
2017 did not have a relationship with patient demographics including: type of DM, 
age in 2017, years diagnosed with DM in 2017, attendance rate to provider visits 
in 2017, gender, ethnicity, insurance coverage, and county of residence.  
Alternative Hypothesis: The average HgbA1c in 2017 did have a relationship with 
patient demographics including: type of DM, age in 2017, years diagnosed with 
DM in 2017, attendance rate to provider visits in 2017, gender, ethnicity, 
insurance coverage, and county of residence. 
Minimizing Risks 
VCH HIPPA and PHI guidelines were followed to prevent legal and social 
risk for subjects.  All data was stored in a locked area and with a password 
protected computer, which the researcher had exclusive access to.  In addition, the 
DNP Data Instrument, a Microsoft Excel worksheet, used to collect patient data 
with identifying patient information had all identifying information removed prior 
to being analyzed by the California State University, Fresno Statistics lab.  
Specifically, an initial data sheet required a medical record identification number 
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and date of birth to prevent duplication in data entry.  Once data was verified and 
the audit complete, the data sheet was saved without the identifying information 
and the de-identified data was analyzed for the purpose of this study.  Data was 
also coded to protect patient privacy and facility data analysis, please see attached 
coding key for details (see Appendix B-DNP Coding Key). 
No paper documentation was used to complete this study.  All computer 
data with identifying patient data was housed in a VCH password protected 
computer, which the researcher had exclusive access to.  The computer was stored 
in a locked area when not in use.  
Limitations 
This project was faced with limitations.  The greatest limitation was time 
allowed to complete the DNP project.  The study was conducted over three months 
to meet DNP program guidelines.  The study was limited to patients aged eighteen 
to twenty-one years old due to patients under the age of eighteen being a protected 
population.  The upper limit of age twenty-one was due to California Children’s 
Services insurance ending at age twenty-one and patients no longer being seen at 
VCH. Issues with measurements were controlled by verifying HgbA1c analysis 
machine was validated per VCH protocols.  
Compensation, Consent, and Approval 
  No compensation was provided to subjects due the study being  
retrospective. Written consent forms did not apply to the study due to no more 
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than minimal risk to subjects and being a retrospective audit of documentation.  In 
addition, an aspect of this study was capturing the number of patients lost to 
follow-up, as they got older.  Due to feasibility and minimal risk a waiver of 
informed consent was granted by VCH institutional Review Board (IRB) (see 
Appendix E-VCH Waiver). This study was approved by VCH IRB and California 
State University, Fresno School of Nursing IRB (see Appendix F-Fresno State and 
VCH IRB Approval).  
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CHAPTER 4: RESULTS 
The sample consisted of 226 subjects. The sample demographics included 
69% diagnosed with Type 1 DM and 31% diagnosed with Type 2 DM. Subjects 
born in 1997 were 23%, 1998 31%, and 1999 45% of the sample. The majority 
had DM for five years of less, 50%, while 32% had DM for six to ten years, and 
19% had DM for eleven years or more.  Males made up 57% and females 43% of 
the sample. Ethnicity of the sample included 2% Asian, 4% Black, 60% Hispanic, 
30%White, and 4% other. The majority of the sample used Medi-Cal CCS as their 
insurance, 79%, while 18% had private insurance, 2% had both private and Medi-
Cal CCS insurance, and 1% were cash pay or no insurance. The largest portion of 
the sample lived in Fresno county, 35%, followed by Tulare with 20%, Kern with 
15%, Stanislaus with 10%, Merced with 10%, Madera with 5%, Kings with 4%, 
and less then 1% living in Sacramento, San Joaquin, and San Luis Obispo (see 
Table 1. Sample Demographic Characteristics). 
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Table 1 
        
 Sample Demographic Characteristics             
                
  Total Number      226       
        Number Percentage     
  Type of DM   Type 1 DM 156 69%     
      Type 2 DM 70 31%     
                
  Birth Year   
1997 (20 years old in 
2017) 53 23%     
      
1998 (19 years old in 
2017) 71 31%     
      
1999 (18 years old in 
2017) 102 45%     
                
  
Years with 
diagnosis of DM   5 years or less 113 50%     
      6-10 years 72 32%     
      11 years or more 41 19%     
                
  Gender   Female 97 43%     
      Male 129 57%     
                
  Ethnicity   Asian 5 2%     
      Black 10 4%     
      Hispanic 135 60%     
      White 67 30%     
      Other 9 4%     
                
  Insurance   Medi-Cal CCS 178 79%     
      Private 40 18%     
      
Medi-Cal CCS and 
Private 5 2%     
      
Cash Pay or No 
Insurance 3 1%     
                
  
County of 
Residence   Fresno 78 35%     
      Kern 35 15%     
      Kings 8 4%     
      Madera 12 5%     
      Merced 22 10%     
      Sacramento 1 >1%     
      San Joaquin 1 >1%     
      San Luis Obispo 1 >1%     
      Stanislaus 23 10%     
      Tulare 45 20%     
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Visits and Birth Year 
Four contingency tables were created to test the first hypothesis. Null 
Hypothesis: The attendance rate to appointments between 2014-2017 did not have 
a relationship to patient’s year of birth.  Alternative Hypothesis: The attendance 
rate to appointments between 2014-2017 had a relationship with patient’s year of 
birth. These contingency tables, comparing rate of attendance in  2014, 2015, 
2016, and 2017, to birth year were then analyzed with SPSS software for Chi-
Square Test of Independence (see Appendices D-DNP Data with Contingency 
Tables, G-SPSS Results, and H-DNP Oral defense ppt).  
Comparing visits in 2014 to birth year demonstrated a significant 
relationship between year of birth and attendance rate x2 (1, N =226) = 9.348, p < 
0.05, Cramer’s V = 0.203. For patients born in 1997 (age seventeen years old in 
2014),  24.5% attended two or less visits in a year, while 75.5% attended three or 
more visits in a year. For patients born in 1998 (age sixteen years old in 2014),  
40.8% attended two or less visits in a year, while 59.2% attended three or more 
visits in a year. For patients born in 1999 (age fifteen years old in 2014),  50% 
attended two or less visits in a year, while 50% attended three or more visits in a 
year. Patients who were seventeen years old in 2014 attended the most visits, 
while patients who were fourteen years old in 2014 attended the least. For 2014 
visits the  Null Hypothesis was rejected and the Alternative Hypothesis was 
accepted (see Figure 1. Visits 2014). 
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x2 (1, N =226) = 9.348, p < 0.05, Cramer’s V = 0.203 
Figure 1. Visits 2014 
Comparing visits in 2015 to birth year did not demonstrate a significant 
relationship between year of birth and attendance rate x2 (1, N =226) = 2.932, p > 
0.05, Cramer’s V = 0.114. For 2015 visits the  Null Hypothesis was accepted and 
the Alternative Hypothesis was rejected. 
Comparing visits in 2016 to birth year demonstrated a significant 
relationship between year of birth and attendance rate x2 (1, N =226) = 7.584, p < 
0.05, Cramer’s V = 0.183. For patients born in 1997 (age nineteen years old in 
2016),  83% attended two or less visits in a year, while 17% attended three or 
more visits in a year. For patients born in 1998 (age eighteen years old in 2016),  
74.6% attended two or less visits in a year, while 25.4% attended three or more 
visits in a year. For patients born in 1999 (age seventeen years old in 2016),  
62.7% attended two or less visits in a year, while 37.3% attended three or more 
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visits in a year. Patients who were seventeen years old in 2016 attended the most 
visits, while patients who were nineteen years old in 2016 attended the least. For 
2016 visits the  Null Hypothesis was rejected and the Alternative Hypothesis was 
accepted (see Figure 2. Visits 2016). 
 
x2 (1, N =226) = 7.584, p < 0.05, Cramer’s V = 0.183 
Figure 2. Visits 2016 
Comparing visits in 2017 to birth year did not demonstrate a significant 
relationship between year of birth and attendance rate x2 (1, N =226) = 3.178, p > 
0.05, Cramer’s V = 0.119. For 2017 visits the  Null Hypothesis was accepted and 
the Alternative Hypothesis was rejected. 
HgbA1c and Demographics 
Eight contingency tables were created to test the second hypothesis with 
Chi-Square Test of Independence using SPSS software (see Appendices D-DNP 
Data with Contingency Tables and G-SPSS Results). Null Hypothesis: The 
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average HgbA1c in 2017 did not have a relationship with patient demographics 
including: type of DM, age in 2017, years diagnosed with DM in 2017, attendance 
rate to provider visits in 2017, gender, ethnicity, insurance coverage, and county of 
residence.  Alternative Hypothesis: The average HgbA1c in 2017 did have a 
relationship with patient demographics including: type of DM, age in 2017, years 
diagnosed with DM in 2017, attendance rate to provider visits in 2017, gender, 
ethnicity, insurance coverage, and county of residence.   
Comparing type of DM to average HgbA1c in 2017 demonstrated a 
significant relationship between type of DM and HgbA1c rate x2 (1, N =226) = 
17.454, p < 0.05, Cramer’s V = 0.278. For patients with Type 1 DM in 2017, 
19.2% had an average HgbA1c of 7.5% or less, 38.5% had an average HgbA1c of 
7.6%-9.5%, 25% had an average HgbA1c of 9.6%-11.5%, and 17.3% had an 
average HgbA1c of 11.6% or more.  For patients with Type 2 DM in 2017, 42.9% 
had an average HgbA1c of 7.5% or less, 22.9% had an average HgbA1c of 7.6%-
9.5%, 12.9% had an average HgbA1c of 9.6%-11.5%, and 21.4% had an average 
HgbA1c of 11.6% or more.  Patients with Type 2 DM had the highest rates of 
controlled DM with a HgbA1c 7.5% or less, but also the highest rates of the least 
controlled DM with HgbA1c of 11.6% or more.  Type 1 DM were most likely to 
have a HgbA1c of 7.6% to 11.5%. For type of DM  the Null Hypothesis was 
rejected and the Alternative Hypothesis was accepted (see Figure 3. Type of DM). 
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x2 (1, N =226) = 17.454, p < 0.05, Cramer’s V = 0.278 
Figure 3. Type of DM 
Comparing age in 2017 to average HgbA1c in 2017 did not demonstrate a 
significant relationship between age and average HgbA1c x2 (1, N =226) = 12.346, 
p > 0.05, Cramer’s V = 0.165. For age in 2017 the Null Hypothesis was accepted, 
and the Alternative Hypothesis was rejected. 
Comparing number of years with diagnosis of DM in 2017 to average 
HgbA1c in 2017 demonstrated a significant relationship between years of 
diagnosis and average HgbA1c rate x2 (1, N =226) = 21.299, p < 0.05, Cramer’s V 
= 0.217. For patients diagnosed five years or less in 2017, 36.3% had an average 
HgbA1c of 7.5% or less, 25.7% had an average HgbA1c of 7.6%-9.5%, 14.2% had 
an average HgbA1c of 9.6%-11.5%, and 23.9% had an average HgbA1c of 11.6% 
or more.  For patients diagnosed six to ten years prior to 2017, 18.1% had an 
average HgbA1c of 7.5% or less, 41.7% had an average HgbA1c of 7.6%-9.5%, 
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27.8% had an average HgbA1c of 9.6%-11.5%, and 12.5% had an average 
HgbA1c of 11.6% or more.  For patients diagnosed eleven years or more prior to 
2017, 14.6% had an average HgbA1c of 7.5% or less, 41.5% had an average 
HgbA1c of 7.6%-9.5%, 29.3% had an average HgbA1c of 9.6%-11.5%, and 
14.6% had an average HgbA1c of 11.6% or more.  Patients diagnosed with DM 
for five years or less were the most likely to have controlled DM with a HgbA1c 
of 7.5%, while patients diagnosed for eleven years or more were the least likely. 
The majority of patients diagnosed for six years or more had an average HgbA1c 
of 7.6%-9.5%. For number of years with diagnosis of DM the Null Hypothesis 
was rejected and the Alternative Hypothesis was accepted (see Figure 4. Years 
with diagnosis). 
 
x2 (1, N =226) = 21.299, p < 0.05, Cramer’s V = 0.217 
Figure 4. Years with diagnosis 
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Comparing number of attended provider visits in 2017 to average HgbA1c 
in 2017 demonstrated a significant relationship between visits and average 
HgbA1c  x2 (1, N =226) = 18.124, p < 0.05, Cramer’s V = 0.200. For patients who 
attended one visit in 2017, 25% had an average HgbA1c of 7.5% or less, 21.2% 
had an average HgbA1c of 7.6%-9.5%, 21.2% had an average HgbA1c of 9.6%-
11.5%, and 32.7% had an average HgbA1c of 11.6% or more.  For patients who 
attended two visits in 2017, 28% had an average HgbA1c of 7.5% or less, 28% 
had an average HgbA1c of 7.6%-9.5%, 23.2% had an average HgbA1c of 9.6%-
11.5%, and 20.7% had an average HgbA1c of 11.6% or more.  For patients who 
attended three or more visits in 2017, 26.1% had an average HgbA1c of 7.5% or 
less, 45.7% had an average HgbA1c of 7.6%-9.5%, 19.6% had an average 
HgbA1c of 9.6%-11.5%, and 8.7% had an average HgbA1c of 11.6% or more. 
Patients who attended two visits had the highest rates of controlled DM with a 
HgbA1c 7.5% or less while patients who attended one visit had the lowest rates. 
Patients who attended three or more visits had the lowest rates of HgbA1c 11.6% 
or more while patients who attended one visit had the highest. Patients who 
attended three or more visits had the highest rate of HgbA1c 7.6%-9.5%, while 
patients who attended two visits had the highest rate of HgbA1c 9.6%-11.5%. For 
visits in 2017 compared to HgbA1c in 2017 the Null Hypothesis was rejected, and 
the Alternative Hypothesis was accepted (see Figure 5. Visits 2017 and HgbA1c). 
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x2 (1, N =226) = 18.124, p < 0.05, Cramer’s V = 0.200 
Figure 5. Visits 2017 and HgbA1c 
Comparing  gender to average HgbA1c in 2017 did not demonstrate a 
significant relationship between gender and average HgbA1c x2 (1, N =226) = 
1.526, p > 0.05, Cramer’s V = 0.082. For gender the Null Hypothesis was 
accepted, and the Alternative Hypothesis was rejected. 
Comparing ethnicity to average HgbA1c in 2017 did not demonstrate a 
significant relationship between ethnicity and average HgbA1c x2 (1, N =226) = 
9.995, p > 0.05, Cramer’s V = 0.149. For ethnicity the Null Hypothesis was 
accepted, and the Alternative Hypothesis was rejected. 
Comparing insurance coverage type to average HgbA1c in 2017 did not 
demonstrate a significant relationship between insurance and average HgbA1c x2 
(1, N =226) = 13.543, p > 0.05, Cramer’s V = 0.141. For insurance type the Null 
Hypothesis was accepted, and the Alternative Hypothesis was rejected. 
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Comparing current county or residence to average HgbA1c in 2017 did not 
demonstrate a significant relationship between county and average HgbA1c x2 (1, 
N =226) = 11.965, p > 0.05, Cramer’s V = 0.133. For current county or residence, 
the Null Hypothesis was accepted, and the Alternative Hypothesis was rejected. 
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CHAPTER 5: CONCLUSION 
No statistically significant relationship was found between year of birth and 
visits in 2015 and 2017.  However, for 2014 and 2016 visits in relationship to year 
of birth, a significant relationship was found.  Both of these variables 
demonstrated that patients who were seventeen years old had the highest rates of 
attending three or more visits in a year. For visits in 2014, patients who were the 
youngest, fourteen years old, were the least likely to attend visits.  This may be 
due to inclusion criteria for the study was being diagnosed with DM by 2017, 
therefore patients who had not yet been diagnosed with DM and had no visits in 
2016, 2015, and 2014 were included in the study. For visits in 2016 the group least 
likely to attend visits were nineteen year-olds, born in 1997, making them the 
oldest age group studied in 2016.  In regards, to teaching transition to adult care 
skills to AYAs, it appears that patients who are seventeen years old are the optimal 
age group to target because they are most likely to attend the most provider visits.  
Before this age some patients may not have been diagnosed with DM yet, and 
after this age rates of attending provider visits decreases.  
No statistically significant relationship was found between age, gender, 
ethnicity, insurance, and county with average HgbA1c in 2017.  There were three 
demographic categories that did demonstrate significant relationship with average 
HgbA1c in 2017.  These categories included type of DM, years since diagnosis of 
DM in 2017, and rate of attendance to provider visits in 2017. 
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Patients with Type 2 DM had the highest rates of controlled DM, but also 
the highest rates of the least controlled DM.  Type 1 DM had the highest rates of 
moderately uncontrolled DM with HgbA1cs of 7.6%-11.5%. More research may 
be needed to understand this phenomenon but may be attributed to some Type 2 
DM having HgbA1c controlled with lifestyle interventions and others requiring 
insulin.  
Patients diagnosed with DM for five years or less were the most likely to 
have controlled DM with a HgbA1c of 7.5% or less, while patients diagnosed for 
eleven years or more had the lowest rates of controlled DM.  It appears that the 
longer a patient has DM, rates of controlled DM decreases.  
Patients who attended two visits had the highest rates of controlled DM 
with a HgbA1c 7.5% or less while patients who attended one visit had the lowest 
rates. This may be due to some providers scheduling controlled Type 2 DM for 
follow visits every six months instead of three.  Patients who attended three or 
more visits had the lowest rates of HgbA1c 11.6% or more, while patients who 
attended one visit had the highest. Patients who attend one visit are the most likely 
to have the most poorly controlled DM and the least likely to have controlled DM.  
 AYAs who are at the highest risk of having uncontrolled DM are patients 
who attend one visit per year, have had DM for eleven years or more, and have 
Type 2 DM.  Patients from this population who have the highest rates of 
controlled DM attend two visits per year, have had DM for five years or less, and 
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have Type 2 DM. Special considerations to target patients with low attendance to 
follow-up visits, have had DM for longer periods of time, and have Type 2 DM 
would be vital in providing effective transition to adult care education. It is also 
important to note that 81% of the sample used Medi-Cal CCS insurance and 60% 
identified as Hispanic.  It would be essential to incorporate insurance issues and 
culturally appropriate care into education materials developed for this population.  
Future Research Recommendations 
There are still many issues that need to be researched to create successful 
transition to adult care programs. Long-term studies on the effectiveness of 
transitional programs are still needed.  More research is still needed to create 
formalized and standardized transitional tools and measurements of success for 
transitional programs. There are also questions this study brought to light.  Patients 
with Type 2 DM had the highest rates of controlled DM with a HgbA1c 7.5% or 
less, but also the highest rates of the least controlled DM with HgbA1c of 11.6% 
or more.  This is a phenomenon that could be further explored in research. More 
studies evaluating patients with Type 2 DM and transition to adult care are needed. 
Impact on Nursing 
The results of the study will have implications for future nursing practice.  
The study identified that seventeen years old is the ideal age to provide transition 
to adult care education to AYAs with DM.  In addition, the study identified that 
patients with Type 2 DM, have had the diagnosis of DM for eleven years or more, 
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and attend one visit per year have the lowest rates of controlled DM in this 
population.  This information can be used to create a targeted transition to adult 
care education intervention for pediatric patients with DM at this age.  This 
education could possibly improve DM control during the transition to adult care 
and increase knowledge of how to transition to adult care.  General benefits of this 
study include increasing knowledge and awareness of how to support and provide 
demographic and age targeted education to AYAs with DM transitioning to adult 
care. There are also potentially specific benefits for improving nursing care 
provided to children who live below the federal poverty level in California with 
DM using Medi-Cal CCS as their primary insurance and Hispanic children.  
The results of the study can be shared with diabetes educators and nursing 
administrations to create consensus and support for creating a formalized 
transitional program that is initiated for patients who are seventeen years old with 
DM.  Zion et al. (2018) have already validated that nurse-led transitional programs 
are effective. This study may be the first step in creating a nurse-led transitional 
clinic for pediatric patients with DM transitioning to adult care at VCH.   
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APPENDIX A: DNP DATA INSTRUMENT 
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Subject 
ID #  
Athena 
#/DOB  
Year 
of 
Birth  
Age 
1/1/17  
# 
yr 
w/ 
dx  
insurance  Ethnicity  Gender  County  
Type 
of 
DM  
visits 
2014  
visits 
2015  
visits 
2016  
visits 
2017  
HgbA1c 
2017  
   39
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 DNP Data Coding Key  
Column A: Subject ID # 
A unique code assigned by the researcher.  
 
Column B: patient identify (removed for analysis and write-up) Pt initials, Athena 
number, and date of birth  
 
Column C: Year of Birth 
1 - 1997 (20 years old)  
2 - 1998 (19 years old)  
3 - 1999 (18 years old)  
 
Column D: Age on 1/1/17  
1 - 18 yrs  
2 - 19 yrs  
3 - 20 yrs  
 
Column E: Number of years since diagnosis of DM to 2017 (rounded up to years) 
0 – Less than 6 months  
1 – 1 year to 5 years 
2 – 6 years to 10 years 
3 – 11 years to 15 years 
4 – 16 years to greater than 20 years  
 
Column F: Insurance Type in 2017 
1 – California Children’s Services (CCS) and/or Medi-Cal 
2 – Private insurance (Preferred Provider Organization or Health Maintenance  
Organization) 
3 – Both CCS or Medi-Cal and Private Insurance 4 – Cash pay or No insurance 
5 - Other  
 
Column G: Ethnicity  
1 - Asian  
2 - American Indian/Native Alaskan 
3 - Black/African American 
4 – Hispanic/Latino 
5 - Native Hawaiian/ other Pacific islander 
 6 - White  
7 - Other/not listed  
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Column H: Gender  
1 - Female  
2 - Male 
3 - Other/not list  
 
Column I: Current county of Residence, California County Codes  
1 – Alameda  
2 – Alpine 
3 – Amador 
4 – Butte 
5 – Calaveras 
6 – Colusa 
7 – Contra Costa 
8 – Del Norte 
9 - El Dorado 
10 – Fresno 
11 – Glenn 
12 – Humboldt 
13 – Imperial 
14 – Inyo 
15 - Kern 
16 – Kings 
17 – Lake 
18 – Lassen 
19 – Los Angeles 
20 – Madera 
21 – Marin 
22 – Mariposa 
23 – Mendocino 
24 – Merced 
25 – Modoc 
26 - Mono 
27 – Monterey 
28 – Napa 
29 – Nevada 
30 – Orange 
31 – Placer 
32 – Plumas 
33 – Riverside 
34 – Sacramento 
35 – San Benito 
36 – San Bernardino 37 – San Diego 
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38 – San Francisco 39 – San Joaquin 
40 – San Luis Obispo 41 – San Mateo 
42 - Santa Barbara 43 – Santa Clara 
44 – Santa Cruz  
45 – Shasta 
46 – Sierra 
47 – Siskiyou 48 – Solano 
49 – Sonoma 50 – Stanislaus 51 – Sutter  
52 – Tehama 53 – Trinity 
54 – Tulare 
55 – Tuolumne 56 – Ventura 57 – Yolo  
58 – Yuba  
 
Column J: Type of DM: Defined by ICD 10-codes  
1 - Type 1 DM: ICD 10- E10.65 and E10.9  
2 - Type 2 DM: ICD 10- E11.65 and E11.9  
 
Column K, L, M, N: Number of Provider (NP or MD) visits between 2014-2017 
0 – 0 visits in a year (including not yet diagnosed with DM or lost to follow-up) 
 1 – 1 visit per year 
2 – 2 visits per year 
3 -3 visits per year 
4 - 4 or more visits per year  
 
Column O: Average HgbA1c in 2017 
0 – 0 visits in year group, no HgbA1c available  
1 - 7.5% or less 
2 - 7.6%-9.5% 
3 - 9.6%- 11.5% 
4 - 11.6%-13.5% 
5 - 13.5% or More  
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Valley Children’s Healthcare  
 
Policy/Procedure 
Number  
 
HC-0020  
 
Policy/Procedure Name  
 
Information Technology Data Sanitization Policy  
 
Type of 
Policy/Procedure  
 
Valley Children’s Healthcare - Information Management  
 
Date Approved  
 
07/17  
 
Date Due for Review  
 
 
02/20  
 
Policy/Procedure 
Description  
 
Establishes policy for the sanitization and/or destruction of hospital 
owned electronic devices.  
 
Supersedes  
 
IM-1018, Information Management, Information Technology Data 
Sanitization Policy 
AD-1018, Administration, Information Technology Data Sanitization 
Policy  
1.1739, Policy: Organization & Governance, ITS Retired Equipment 
Sanitization 
1.1739, Policy: Organization & Governance, Sanitization and Data 
Removal Process for Retired IT Equipment  
AD-1018, Admin-IT, ITS Retired Equipment Sanitation  
 
Purpose Statement  
The purpose of this policy is to ensure that all confidential data is permanently removed from 
hospital devices prior to their reuse, or disposal.  
Scope  
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This policy applies to all users of Valley Children’s Hospital (Hospital) information technology 
resources including, but not limited to, all employees, physicians, volunteers, vendors, 
contractors, and employees or affiliated organizations. Employees include all staff, administrators, 
full- or part-time, who are paid by the hospital.  
This policy applies to all electronic devices owned by Hospital that have the ability to store data 
including but not limited to computers, thumb drives, memory cards, PDA’s, flash cards, or any 
other device that can store data. (Reference NIST publication 800-88 revision 1 for a list of media 
types.)  
Policy  
In the event that hospital owned electronic devices are marked for destruction, donation or 
redeployment, all data residing on the hospital owned device is to be destroyed or thoroughly 
sanitized such that there is reasonable assurance that no usable data remains on the devices.  
The Family Educational Rights and Privacy Act (FERPA), the Gramm-Leach-Bliley Act (GLBA), 
the Health Insurance Portability and Accountability Act of 1996 (HIPAA), and Payment Card 
Industry Data Security Standards (PCI DSS) require formal documentation of disposal 
procedures to ensure specific types of information is properly sanitized prior to being discarded.  
Sanitation Methods  
The National Institute of Standards and Technology (NIST) has defined four methods of data 
sanitization. These four methods are as follows:  
•  		Disposal  
Defined as the act of discarding media with no other sanitization considerations. 
Examples of Disposal include discarding paper in a recycling container, deleting 
electronic documents using standard file deletion methods and discarding electronic 
storage media in a standard trash receptacle.  
•  		Clearing 
Defined as a level of sanitization that renders media unreadable through normal means. 
Clearing is typically accomplished through an overwriting process that replaces actual 
data with 0’s or  
1  
Valley Children’s Healthcare  
random characters. Clearing prevents data from being recovered using standard disk and file 
recovery utilities.  
•  		Purging 
An advanced media sanitization process that protects the confidentiality of information 
against a laboratory attack. This type of attack involves using signal processing 
equipment and specially trained personnel. Executing a 7-pass-wipe and degaussing are 
examples of acceptable methods for purging. In many cases, the same tool can be used 
for clearing and purging the information.  
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•  		Destroying 
Destruction of media is the ultimate form of sanitization. After media are destroyed, they 
cannot be reused as originally intended. Physical destruction can be accomplished using 
a variety of methods, including disintegration, incineration, pulverizing, shredding, and 
melting.  
General Sanitization  
•  		The Valley Children’s Hospital IT department and the biomedical department are the 
only authorized departments to sanitize or dispose of electronic storage equipment 
owned or managed by the hospital.  
•  		Staff, physicians, contractors and other non-IT personal cannot destroy, resell or 
otherwise remove hospital-owned or managed equipment except through this process.  
•  		All electronic storage media will be sanitized when it is no longer necessary for 
business use, provided that the sanitization does not conflict with data retention policies, 
or any regulatory requirements. Questions about retention requirements should be 
directed toward the appropriate data owner.  
•  		All electronic storage media is to be sanitized prior to sale, donation or transfer of 
ownership. A transfer of ownership may include transitioning devices interdepartmentally, 
to another department, or replacing media as part of a service agreement.  
Media reuse sanitization  
•  		Electronic storage media that is removed from a department and is to be reused within 
the organization will have all data cleared to prevent unauthorized disclosure.  
•  		Data will be cleared using a method consistent with the NIST 800-88 specification and 
according to the media type.  
Retired media sanitation  
•  		Electronic storage media leaving control of the organization and destined for reuse by 
another organization or final disposal must have all data purged in a manner that renders 
the data unrecoverable.  
•  		Data is to be purged using a method consistent with the NIST 800-88 specification and 
according to the media type.  
•  		Electronic storage media must be physically destroyed when other approved 
sanitization methods are not effective. Approved methods for physical destruction include 
shredding, pulverizing, disintegration or incineration.  
Responsibilities  
•  		The Information Security Officer will establish and oversee disposal of electronic 
devices accordance with this policy.  
•  		Information technology department managers will ensure that equipment under the 
management of their department is disposed of in accordance with this policy.  
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•  		Biomedical department management will ensure that equipment under the 
management of their department is disposed of in accordance with this policy.  
•  		Information technology department managers must maintain records of the data 
sanitization method used when electronic devices are retired or ownership is transferred 
to another organization.  
•  		The biomedical department must report data sanitations to the Information technology 
department so records can be maintained  
Definitions 
Degaussing 
Exposing the magnetic media to a strong magnetic field in order to disrupt the recorded 
magnetic domains. Degaussing can be an effective method for purging damaged media, 
for purging media with exceptionally large storage capacities, or for quickly purging 
diskettes. Degaussing is not effective for purging nonmagnetic media, such as optical 
media [compact discs (CD), digital versatile discs (DVD), etc.).  
Disk Wipe  
A procedure that uses a single character to overwrite all addressable locations on a hard 
drive.  
Re-image  
To reconfigure a new PC by overwriting the installed operating system with the same or 
different one, but combined with drivers, applications and settings required by the users.  
Media  
Material on which data are or may be recorded, such as magnetic disks or tapes, solid 
state devices like USB flash drives, optical discs like CDs and DVDs and integrated 
storage devices such as smart phones and iPads.  
Media sanitization  
The process of removing data from storage media such that there is reasonable 
assurance that the data may not be retrieved and reconstructed.  
Pulverization  
A physically destructive method of sanitizing media.  
 
References/Regulations  
 
 
C.F.R. § 164.316 (b)(2)(i); C.F.R. § 164.316 (b)(2)(ii); C.F.R. § 164.316 
(b)(2)(iii) 
NIST publication 800-88  
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Policy/Procedure Name  
 
Information Technology Data Classification Policy  
 
Type of 
Policy/Procedure  
 
Valley Children’s Healthcare - Information Management  
 
Date Approved  
 
05/18  
 
Date Due for Review  
 
 
05/21  
 
Policy/Procedure 
Description  
 
The purpose of this policy is to outline the required data protections 
based on classification and sensitivity.  
 
Supersedes  
 
IM-1032, Information Management, Information Technology Data 
Classification Policy 
AD-1032, Administration, Information Technology Data Classification 
Policy  
 
Purpose Statement  
Valley Children’s Healthcare and its subsidiary entities, Valley Children’s Hospital, Valley 
Children’s Medical Group and Valley Children’s Healthcare Foundation (collectively, the 
“Healthcare Network”)is committed to the protection of confidential information. Classifying data is 
a method of assigning a level of sensitivity to data. The classification of the data determines the 
extent to which it needs to be controlled and secured. This policy defines the guidelines to be 
used in establishing required data protection criteria based on the type of data at issue, its 
classification and sensitivity.  
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Scope  
This policy applies to all users of Healthcare Network data and information technology resources. 
This policy governs all information technology resources whether owned by or operated for the 
Healthcare Network through contractual arrangements, including, but not limited to, all 
employees, physicians, volunteers, vendors, contractors, employees of affiliated organizations, 
and visitors to the institution.  
Policy  
All workforce members of the Healthcare Network have a responsibility to protect the 
confidentiality, integrity and availability of Healthcare Network data from unauthorized generation, 
access, modification, disclosure, transmission or destruction, and are expected to be familiar with 
and comply with this policy.  
Data owned, used, created or maintained by the Healthcare Network is classified into the 
following three categories:  
1. Public  
2. Sensitive  
3. Confidential  
(Low Risk) 
(Internal Use; Moderate Risk) (High Risk)  
Data Classifications  	Public Data (Low Risk)  
Definition  
Public data is information that may or must be open to the general public. It is defined as 
information with no existing corporate, local, national or international legal restrictions on access 
or usage. Public data, while subject to hospital disclosure rules, is available to all employees and 
to all individuals and entities external to the organization.  
Protections  
Protection of this data is at the discretion of the data owner  
Examples  
By way of illustration only, some examples of Public Data include: o Publicly posted press 
releases 
o Maps, directions and organization descriptions 
o Organizational Charts  
o Annual Reports  
1  
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o Press Statements  
o Marketing Materials   	Sensitive Data (Internal Use; Moderate Risk) Definition  
Sensitive Data is information that must be guarded due to proprietary, ethical, or privacy 
considerations, and must require protection from unauthorized access, modification, 
transmission, storage or other use. This classification applies even though there may not be a 
civil statute requiring this protection. Compromise of Sensitive Data may inconvenience the 
organization, but is unlikely to result in a breach of confidentiality, loss of value or serious damage 
to integrity. Sensitive Data is information that is restricted to members of the organization who 
have a legitimate purpose for accessing such data and may be disclosed to other external 
individuals with the proper consent.  
Protections  
o Must be protected to prevent unauthorized access and/or unauthorized disclosure. 
o May require protection to prevent loss from system failures such as backups. (discretion  
of the data owner)  
o Must be stored in a nonpublic location (i.e. file cabinet, closed office, or department where 
physical controls are in place to prevent disclosure) when not in use.  
o Must not be posted on any public website. 
o Must be destroyed when no longer needed subject to data sanitation policies.  
Examples  
By way of illustration only, some examples of Sensitive Data include: 
o Internal phone books and directories 
o Technical procedures and processes and configuration documents o Healthcare Network 
policies and procedures  
o Meeting Minutes 
o Internal Project Reports 
o Public Video Surveillance Footage   	Confidential Data (High Risk) Definition  
Confidential Data is information protected by statutes, regulations, organizational policies or 
contractual language. Data owners may also designate data as Confidential. Confidential Data 
may be disclosed to individuals on a need-to-know basis only. Disclosure to parties outside the 
organization should be authorized by executive management and/or the Senior Vice-President, 
Chief Legal Officer.  
Protections  
 52 52 
o When stored in an electronic format, must be protected with effective passwords and stored on 
systems that have protection against loss, theft, unauthorized access and unauthorized 
disclosure.  
o Requires multi-factor authentication when available remotely via the Internet. 
o Must not be disclosed to parties without explicit authorization by the data owner and in  
accordance with state and federal regulations. 
o When stored, must be stored only in a locked drawer or room or an area where access  
is controlled by a guard, cipher lock, and/or card reader, or that otherwise has sufficient physical 
access control measures to afford adequate protection and prevent unauthorized access by 
members of the public, visitors, or other persons without a need-to-know.  
o When transported, must be transported only in a locked box, case, bag, or device/technology 
and stored during transport in a location that otherwise has sufficient  
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physical access control measures to afford adequate protection and prevent unauthorized access 
by members of the public, visitors, or other persons without a need-to-know. (An example, brief 
case with lock and stored in trunk of car).  
o When sent via fax must be sent only to a previously established and used address or one that 
has been verified as using a secured location.  
o Must not be posted on any public website. 
o When sent to an external email address, must use encryption technology. 
o Must be protected with FIPS 140-2 encryption technology when stored outside the  
protected datacenter systems in digital format. 
o Must be destroyed when no longer needed subject to data sanitation policies  
.  
Examples  
By way of illustration only, some examples of Confidential Data include:  
•  		Protected Health Information (PHI)  
•  		Electronic Protected Health Information (ePHI)  
•  		Credit Card Numbers  
•  		Social Security Numbers  
•  		Financial Records  
•  		Payroll Information  
•  		Personnel Records  
•  		Trade Secrets Roles and Responsibilities  
 53 53  	Data Owner 
o Data Owners are Healthcare Network leaders having direct operational-level  
responsibility for information management, usually department directors. Data Owners  
are responsible for data access and policy implementation issues. 
o All organizational information must have an associated data owner. 
o The data owner is responsible for classifying the data into one of the above categories. o The 
data owner is responsible for ensuring that the data is protected according to the  
classification.   	Data Custodian 
o Information Technology Services (ITS) is the data custodian. The custodian is  
responsible for providing a secure infrastructure in support of the data including, but not limited to, 
providing physical security, backup and recovery processes, granting access privileges to 
authorized system users and implementing and administering controls over the information.  
o The data custodian is responsible to protect information according to the classification.   	Data User 
o Data users are individuals who need and use Healthcare Network data as part of their  
assigned duties. Individuals who are given access to sensitive data have a position of  
special trust and are thus responsible to protect the security and integrity of the data. o The data 
users have authorized access to information by the data owner.  
Failure to comply with any or all of this policy may result in corrective action up to, and including, 
termination of employment.  
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APPENDIX D: DNP DATA WITH CONTINGENCY TABLES 
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Subj
ect 
ID # 
I
D 
Year 
of 
Birt
h 
A
g
e  
# 
yr 
w/ 
dx 
ins
ura
nce 
Et
hni
cit
y 
Ge
nd
er 
Co
un
ty 
Ty
pe 
DM 
visit
s 
201
4 
visit
s 
201
5 
visit
s 
201
6 
visit
s 
201
7 
Hgb
A1c 
2017 
1 
Ban    1 2 2 1 4 2 10 1 4 4 2 4 2 
2 
Ban    2 1 2 2 6 2 54 1 4 4 2 1 2 
3 
Ban   3 1 2 1 6 1 54 1 2 3 2 4 1 
4 
Ban   3 1 3 3 4 1 24 1 2 3 1 4 2 
5 
Ban   3 2 2 1 4 2 10 1 4 3 2 4 2 
6 
Ban   3 1 2 1 4 1 15 1 4 4 3 4 3 
7 
Ban   3 1 4 3 4 2 54 1 4 3 0 3 2 
8 
Ban   1 3 3 1 3 1 10 1 2 1 1 1 4 
9 
Ban   2 1 2 1 1 2 10 2 4 4 1 4 3 
10 
Ban   3 1 1 1 4 1 50 2 0 0 3 2 1 
11 
Ban   1 3 2 2 6 2 24 1 3 4 1 4 4 
12 
Ban   3 1 3 1 4 2 10 1 4 3 2 3 2 
13 
Ban   3 1 3 1 6 2 24 1 3 3 2 4 2 
14 
Ban   3 1 1 2 3 1 10 1 4 2 3 3 1 
15 
Ban   2 1 3 1 6 2 10 1 3 4 3 3 2 
16 
Ban   1 3 3 1 7 2 24 1 4 3 3 4 1 
17 
Ban   3 1 3 1 4 1 54 1 4 4 2 4 3 
18 
Ban   3 1 2 2 4 2 10 1 4 2 2 3 2 
19 
Ban   1 2 1 1 4 2 10 1 0 2 3 2 1 
20 
Ban   3 1 2 2 4 2 10 2 4 3 2 2 1 
21 
Ban   2 2 2 1 4 2 20 1 4 4 3 4 5 
22 
Ban   1 3 1 1 4 2 10 2 4 1 0 2 4 
23 
Ban   1 2 2 1 4 1 10 1 0 0 2 2 2 
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24 
Ban   3 1 2 1 4 1 20 1 3 2 2 2 1 
25 
Ban   3 1 2 4 7 2 10 1 0 0 1 1 2 
26 
Ban   3 2 2 1 4 1 10 1 4 4 4 3 1 
27 
Ban   3 2 1 1 4 2 54 2 2 3 1 2 1 
28 
Ban   2 2 2 1 3 2 10 1 4 1 1 1 5 
29 
Ban   1 2 2 1 4 2 10 2 4 3 1 4 2 
30 
Ban   2 1 1 1 6 2 24 1 3 4 1 1 4 
31 
Ban   3 2 3 2 4 2 50 1 0 2 0 1 2 
32 
Ban   2 1 3 1 1 2 15 1 4 4 2 3 3 
33 
Ban   1 2 2 1 4 2 15 1 4 3 2 2 2 
34 
Ban   1 3 2 1 4 1 10 1 4 3 2 4 3 
35 
Ban   1 3 3 1 4 1 10 1 4 3 2 2 4 
36 
Ban   2 1 4 2 4 2 54 1 4 3 1 1 3 
37 
Ban   3 1 3 1 4 2 15 1 4 3 3 2 2 
38 
Ban   2 1 3 1 4 1 10 1 3 3 1 4 2 
39 
Ban   3 1 1 2 7 2 16 2 3 4 2 1 1 
40 
Ban   2 1 3 1 6 2 15 1 3 4 2 1 3 
41 
Ban   3 2 2 1 4 2 20 1 4 2 2 3 3 
42 
Ban   2 1 0 1 4 2 54 2 0 0 1 1 1 
43 
Ban   2 1 2 2 6 1 20 1 4 4 2 3 3 
44 
Bri   3 1 2 2 6 1 54 1 3 2 1 2 2 
45 
Bri   2 1 1 1 4 1 10 2 3 4 0 2 4 
46 
Bri   2 1 1 1 4 1 10 2 4 3 3 3 2 
47 
Bri   1 3 2 1 4 2 50 1 3 1 1 2 4 
48 
Bri   2 1 1 1 4 1 24 2 0 1 4 2 2 
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49 
Bri   2 1 1 1 4 1 24 2 0 1 4 2 2 
50 
Bri   3 1 1 1 4 2 10 1 3 3 0 3 4 
51 
Bri   1 2 2 1 4 2 50 2 1 1 3 3 1 
52 
Bri   2 1 1 1 4 1 10 1 3 4 2 3 1 
53 
Bri   2 1 3 4 4 1 54 1 0 0 0 2 2 
54 
Bri   2 1 1 1 6 2 10 1 0 0 2 4 2 
55 
Bri   3 1 1 1 4 1 10 2 3 2 3 2 1 
56 
Bri   3 1 1 1 6 2 54 2 2 4 2 2 2 
57 
Bri   1 2 2 1 6 1 10 1 2 4 2 2 2 
58 
Bri   3 2 1 1 6 2 54 1 2 1 2 2 4 
59 
Bri   3 1 1 1 4 1 24 1 3 4 2 2 3 
60 
Bri   3 1 3 1 4 1 10 1 3 3 2 2 1 
61 
Bri   1 2 1 1 4 1 54 2 3 3 1 2 3 
62 
Bri   2 1 1 1 6 2 10 1 0 3 2 2 2 
63 
Bri   1 2 3 2 6 1 16 1 4 4 2 2 3 
64 
Bri   3 1 1 1 6 2 50 1 0 3 2 2 1 
65 
Bri   2 1 2 1 6 1 10 2 3 1 4 2 2 
66 
Bri   3 1 1 1 4 1 20 2 3 4 3 1 4 
67 
Bri   1 2 2 2 6 2 10 1 4 3 0 2 1 
68 
Bri   2 1 3 1 6 2 50 1 4 4 1 2 2 
69 
Bri   1 2 3 1 6 1 54 1 4 3 3 2 3 
70 
Bri   3 1 0 1 3 2 10 2 0 0 0 1 5 
71 
Bri   3 1 1 1 4 1 10 1 2 2 2 3 2 
72 
Bri   1 2 1 1 4 2 15 1 3 4 1 4 2 
73 
Bri   3 1 1 1 4 1 50 1 4 4 2 3 2 
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74 
Bri   1 2 2 1 4 2 10 1 3 2 0 3 2 
75 
Bri   2 1 1 2 6 1 20 1 0 4 2 4 2 
76 
Bri   2 1 1 1 6 2 24 1 0 2 1 4 2 
77 
Bri   1 2 2 1 4 2 10 1 3 3 3 2 3 
78 
RAM   3 1 1 1 4 2 15 2 0 0 2 2 2 
79 
Ram   1 3 1 1 3 1 10 1 4 1 1 2 4 
80 
Ram   1 3 2 2 6 2 24 1 4 2 1 2 3 
81 
Ram   2 2 2 1 6 1 54 2 2 4 3 2 3 
82 
Ram   2 2 1 1 4 1 54 2 0 3 3 2 4 
83 
Ram   1 3 2 1 3 1 50 1 4 4 1 2 5 
84 
Ram   2 2 2 1 4 1 15 2 4 4 2 1 5 
85 
Ram   3 1 1 1 4 1 20 2 2 2 0 2 3 
86 
Ram   2 2 1 1 3 2 50 2 0 3 1 1 1 
87 
Ram   3 1 1 2 6 2 10 1 3 4 2 2 5 
88 
Men   2 2 2 1 4 1 16 1 2 3 1 2 2 
89 
Men   2 2 1 2 6 2 24 1 3 1 1 3 5 
90 
Men   2 2 3 1 4 1 10 1 3 4 2 1 5 
91 
Men   2 2 3 1 6 1 50 1 0 0 1 1 5 
92 
Men   1 3 4 1 6 2 50 1 3 4 1 4 2 
93 
Men   3 1 1 2 4 1 10 2 3 4 4 3 1 
94 
Men   3 1 2 1 4 1 50 2 0 3 3 1 2 
95 
Men   3 1 3 1 6 1 15 1 0 0 0 3 2 
96 
Men   2 2 1 1 4 1 54 2 1 3 0 3 2 
97 
Men   3 1 2 1 4 1 15 1 4 1 3 3 2 
98 
Men   2 2 2 1 4 1 24 1 4 4 3 4 3 
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99 
Men   3 1 1 3 4 1 10 1 1 1 1 1 5 
100 
Mar   3 1 1 1 4 1 54 2 3 4 2 4 4 
101 
Mar   3 1 1 1 4 2 10 2 0 4 3 3 1 
102 
Mar   2 2 4 1 6 2 16 1 4 3 2 3 1 
103 
Mar   3 1 0 1 6 1 16 2 0 0 1 2 1 
104 
Mar   3 1 0 1 4 2 10 2 0 0 1 1 1 
105 
Mar   3 1 2 1 4 2 54 2 4 3 4 2 1 
106 
Mar   2 2 1 1 4 1 15 2 0 3 1 1 2 
107 
Mar   3 1 1 1 6 1 54 2 2 0 1 1 1 
108 
Mar   2 2 1 1 4 1 24 2 4 4 1 2 1 
109 
Mar   3 1 1 1 6 2 39 2 0 3 2 1 5 
110 
Mar   3 1 1 1 4 2 54 1 0 1 3 3 4 
111 
Mar   3 1 0 2 4 1 10 2 0 0 2 3 2 
112 
Mar   2 2 1 1 3 2 10 2 0 2 1 1 5 
113 
Mar   1 3 2 2 4 2 54 2 4 3 1 2 2 
114 
Mar   3 1 2 2 4 1 10 2 3 2 2 3 1 
115 
Mar   1 3 3 1 3 2 16 2 4 4 2 3 2 
116 
Mar   1 3 1 1 4 2 54 2 0 0 4 3 1 
117 
Boc   3 1 1 2 4 1 15 2 2 1 2 3 1 
118 
Boc   2 2 0 2 6 2 24 2 1 0 1 3 1 
119 
Boc   2 2 2 1 4 2 10 1 4 4 1 2 4 
120 
Boc   3 1 2 1 4 2 10 2 3 1 3 3 1 
121 
Boc   3 1 3 2 6 2 50 1 4 4 1 1 1 
122 
Boc   3 1 2 1 4 1 15 1 4 3 3 2 2 
123 
Boc   3 1 1 1 4 1 20 2 4 4 1 1 3 
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124 
Boc   3 1 1 2 4 2 15 2 0 1 4 4 2 
125 
Boc   2 2 1 1 4 2 15 2 0 3 2 1 1 
126 
Boc   1 3 1 1 7 2 50 1 1 2 2 2 5 
127 
Boc   2 2 1 1 4 2 15 2 4 4 3 4 2 
128 
Boc   3 1 1 1 4 2 54 1 4 4 2 3 2 
129 
Boc   3 1 1 1 4 2 15 2 0 4 2 1 1 
130 
Boc   3 1 1 1 6 2 50 1 0 4 3 4 4 
131 
Boc   2 2 1 1 4 1 50 2 0 1 1 1 4 
132 
Boc   1 3 1 2 4 2 24 2 3 2 3 2 4 
133 
Boc   2 2 1 1 4 1 15 1 2 4 3 4 1 
134 
Boc   2 2 1 1 4 1 10 2 0 0 2 2 1 
135 
Boc   3 1 2 1 6 1 50 1 1 2 2 2 3 
136 
Boc   1 3 2 1 4 2 15 1 4 4 2 4 2 
137 
Boc   3 1 0 1 4 2 54 1 0 0 1 2 1 
138 
Boc   3 1 3 1 4 1 10 1 4 4 2 3 3 
139 
Boc   3 1 1 2 4 2 10 1 2 4 3 4 3 
140 
Boc   2 2 1 1 4 2 20 2 4 4 3 4 3 
141 
Boc   2 2 3 1 6 1 10 1 3 3 1 2 3 
142 
Boc   2 2 2 1 4 2 50 1 3 4 1 3 3 
143 
Boc   3 1 0 2 4 1 15 2 0 0 2 3 2 
144 
Boc   3 1 2 1 4 1 10 1 4 4 1 1 3 
145 
Boc   1 3 3 1 6 1 54 1 3 1 1 1 4 
146 
Boc   3 1 2 1 6 1 10 1 2 3 3 2 2 
147 
Boc   3 1 2 1 4 1 15 1 3 4 3 2 1 
148 
Boc   1 3 1 1 4 2 10 1 1 4 1 2 1 
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149 
Boc   2 2 0 1 4 1 20 2 0 0 1 4 1 
150 
Boc   2 2 1 2 6 2 54 1 4 3 2 2 3 
151 
Boc   2 2 1 1 4 2 24 1 4 4 1 3 3 
152 
Boc   1 3 2 1 6 1 54 1 2 3 0 2 3 
153 
Boc   3 1 1 1 4 1 15 2 0 1 4 4 3 
154 
Boc   3 1 1 1 4 2 10 2 0 4 3 1 3 
155 
Boc   2 2 3 2 4 1 24 1 3 2 2 2 2 
156 
Boc   2 2 3 1 7 1 10 1 3 3 3 3 3 
157 
Boc   2 2 2 1 4 1 10 1 3 3 1 4 3 
158 
Boc   3 1 1 1 4 2 50 1 0 1 3 3 1 
159 
Boc   3 1 1 1 6 2 50 1 0 2 3 2 2 
160 
Boc   3 1 1 1 6 2 24 1 4 3 2 2 3 
161 
Boc   3 1 0 1 4 1 54 2 0 0 1 2 5 
162 
Boc   1 3 2 1 6 2 10 1 4 4 0 1 5 
163 
Boc   3 1 3 1 6 2 50 1 3 2 1 1 2 
164 
Boc   2 2 2 1 4 2 10 1 4 4 3 1 2 
165 
Boc   3 1 3 1 4 2 10 1 4 3 3 3 2 
166 
Boc   2 2 2 1 4 2 54 1 2 4 2 2 2 
167 
Boc   1 3 2 1 6 1 54 1 1 4 3 3 2 
168 
Boc   2 2 1 1 4 2 15 1 4 3 4 3 1 
169 
Cak   2 2 1 1 4 2 54 2 3 2 2 2 4 
170 
Cak   3 1 2 1 4 1 10 1 4 2 3 2 1 
171 
Cak   3 1 1 1 7 2 54 2 1 4 1 4 4 
172 
Cak   3 1 2 1 7 2 54 1 4 3 2 3 2 
173 
Cak   1 3 2 1 4 2 54 1 4 3 2 2 2 
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174 
Cak   3 1 2 1 6 2 50 1 3 4 3 3 2 
175 
Cak   3 1 2 1 4 1 40 1 0 3 2 2 1 
176 
Cak   3 1 0 1 4 1 10 2 0 0 3 2 1 
177 
Cak   3 1 2 1 4 2 24 1 3 3 2 2 3 
178 
Caik   3 1 1 1 4 2 54 1 4 4 2 3 3 
179 
Cak   2 2 1 1 4 2 15 1 0 2 4 4 2 
180 
Cak   1 3 3 1 6 1 54 1 4 3 1 1 3 
181 
Cak   2 3 3 1 4 2 10 1 1 3 2 1 3 
182 
Cak   3 1 0 1 4 2 10 2 0 0 1 1 3 
183 
Cak   3 1 1 1 1 1 10 2 0 1 2 3 1 
184 
Cak   3 1 2 1 4 2 10 1 4 3 3 2 3 
185 
Sha   2 2 3 1 4 1 20 1 4 2 2 3 2 
186 
Sha   3 1 1 1 4 2 10 1 0 2 2 3 1 
187 
Sha   3 1 1 1 6 2 10 1 0 4 1 3 3 
188 
Sha   1 3 1 2 6 2 54 1 4 4 2 1 2 
189 
Sha   3 1 1 2 4 2 10 1 0 2 2 2 4 
190 
Sha   2 2 2 1 4 2 10 1 4 4 2 1 2 
191 
Sha   1 3 2 1 6 2 24 1 4 3 1 2 3 
192 
Sha   2 2 1 2 1 2 54 1 0 1 2 2 1 
193 
Sha   2 2 1 1 6 1 54 1 4 3 2 3 2 
194 
Sha   1 3 3 3 6 1 10 1 4 4 2 1 5 
195 
Sha   1 3 2 1 4 2 15 1 4 3 2 1 3 
196 
Sha   2 2 2 1 4 2 15 1 4 3 2 2 2 
197 
Sha   1 3 2 1 4 1 10 1 2 2 2 3 2 
198 
Sha   3 1 0 2 3 1 10 1 0 0 1 1 1 
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199 
Sha   3 1 1 2 6 2 10 1 4 4 3 2 3 
200 
Sha   1 3 1 1 4 2 16 1 4 3 0 1 4 
201 
Sha   3 1 2 1 6 1 10 1 3 3 3 1 3 
202 
Sha   3 1 1 1 4 2 24 1 4 1 3 1 1 
203 
Sha   1 3 1 2 4 2 10 1 4 3 2 1 1 
204 
Sha   1 3 1 1 4 2 15 1 3 3 1 4 2 
205 
Sha   1 3 1 2 4 2 10 1 4 4 2 2 5 
206 
Sha   3 1 1 2 6 2 10 2 0 1 3 1 1 
207 
Sha   1 3 2 1 4 2 54 2 4 2 0 1 4 
208 
Chi   2 2 2 4 6 2 20 1 3 3 2 1 2 
209 
Chi   2 2 2 1 4 2 10 1 4 2 3 3 1 
210 
Chi   1 3 4 1 1 1 15 1 4 4 2 3 1 
211 
Chi   2 2 1 3 6 2 15 1 0 3 1 1 2 
212 
Chi   2 2 1 1 4 1 54 1 0 3 4 4 2 
213 
Chi   1 3 1 1 4 2 34 1 0 1 1 2 5 
214 
Chi   1 3 3 2 6 1 15 1 1 1 2 2 1 
215 
Chi   1 3 1 2 4 2 54 1 4 3 3 2 2 
216 
Chi   2 2 1 1 6 1 15 2 4 2 1 2 1 
217 
Chi   3 1 1 1 6 2 15 1 4 4 4 2 1 
218 
Chi   3 1 0 1 7 1 15 1 0 0 2 3 2 
219 
Chi   3 1 1 1 6 2 54 2 0 4 3 1 1 
220 
Chi   2 2 0 1 7 2 50 1 0 0 2 4 1 
221 
Chi   3 1 1 1 6 2 24 1 4 4 3 2 3 
222 
Chi   3 1 2 1 6 1 15 1 4 4 4 2 3 
223 
Chi   3 1 0 2 4 2 16 2 0 0 1 3 1 
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224 
Chi   3 1 2 1 6 1 54 1 3 4 2 3 2 
225 
Chi   3 1 1 1 6 2 15 1 0 4 4 3 2 
226 
Chi   1 3 3 1 4 1 54 1 3 1 2 1 3 
 
 Visits 2014 
   
0, 1, & 
2 3 &4 
Tota
l   
Ye
ar
 o
f 
Bi
rt
h 
1 13 40 53   
2 29 42 71   
3 51 51 102   
Total 93 133 226 226  
    226   
 Visits 2015   
   
0, 1, & 
2 3 &4 
Tota
l   
Ye
ar
 o
f 
Bi
rt
h 
1 18 35 53   
2 23 48 71   
3 45 57 102   
Total 86 140 226 226  
    226   
       
 Visits 2016   
   
0, 1, & 
2 3 &4 
Tota
l   
Ye
ar
 o
f 
Bi
rt
h  
1 44 9 53   
2 53 18 71   
3 64 38 102   
Total 161 65 226 226  
    226   
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Visits 2017 
   
0, 1, & 
2 
3 & 
4 
Tota
l   
Ye
ar
 o
f 
Bi
rt
h 
1 37 16 53   
2 40 31 71   
3 57 45 102   
Total 134 92 226 226  
 
       
    226   
 HgbA1c in 2017  
   1 2 3 
4 & 
5 
Tota
l  
Ty
pe
 o
f 
D
M
 1 30 60 
3
9 27 156  
2 30 16 9 15 70  
 Total 60 76 
4
8 42 226 
22
6 
      226  
        
 HgbA1c in 2017  
   1 2 3 
4 & 
5 
Tota
l  
 1 9 17 
1
1 16 53  
Ye
ar
 o
f 
Bi
rt
h 
2 15 28 
1
5 13 71  
3 36 31 
2
2 13 102  
 Total 60 76 
4
8 42 226 
22
6 
      226  
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HgbA1c in 2017 
   1 2 3 
4 & 
5 
Tota
l  
#
yr
 w
/ 
dx
 
 
0 &1 41 29 
1
6 27 113  
2 13 30 
2
0 9 72  
3 & 4 6 17 
1
2 6 41  
 Total 60 76 
4
8 42 226 
22
6 
      226  
 HgbA1c in 2017  
   1 2 3 4 &5 
Tota
l  
V
is
it 
20
17
 
1 13 11 11 17 52  
2 23 23 19 17 82  
3&4 24 42 18 8 92  
Total 60 76 48 42 226 
22
6 
      226  
 
 HgbA1c in 2017   
   1 2 3 4 &5 Total  
G
en
de
r 
1 26 31 24 16 97  
2 34 45 24 26 129  
 Total 60 76 48 42 226 226 
      226  
 
 
 
 
 
 
        
 HgbA1c 2017 
   1 2 3 4 &5 Total  
Et
hn
ic
ity
 4 38 47 27 23 135  
6 13 25 18 11 67  
1,2, 3,5, & 7 9 4 3 8 24  
Total 60 76 48 42 226 226  
     226  
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 HgbA1c 2017  
   1 2 3 4 &5 Total  
In
su
ra
nc
e 1 45 58 41 34 178  
2 15 12 7 6 40  
3 0 3 0 2 5  
4 0 3 0 0 3  
 Total 60 76 48 42 226 226 
      226  
        
 HgbA1c 2017  
   1 2 3 4 & 5 Total  
C
ou
nt
y 
10 23 22 16 17 78  
15 10 18 6 1 35  
54 9 17 10 9 45  
59: 16,20,24,34,39,40, &50 18 19 16 15 68  
 Total 60 76 48 42 226 226 
      226  
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APPENDIX E: VCH Waiver 
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APPENDIX F: Fresno State and VCH IRB Approval 
 74 74 
 
 
 
 75 75 
 
  
 76 76 
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APPENDIX G: SPSS Results 
  
78 78 
 
  
GET
  FILE='C:\Users\gradstud-lab01\Desktop\SaraJennings2014visits data.sav'.
DATASET NAME DataSet1 WINDOW=FRONT.
NEW FILE.
DATASET NAME DataSet2 WINDOW=FRONT.
DATASET ACTIVATE DataSet2.
DATASET CLOSE DataSet1.
GET
  FILE='C:\Users\gradstud-lab01\Desktop\SaraJennings2014visits data.sav'.
DATASET NAME DataSet3 WINDOW=FRONT.
DATASET ACTIVATE DataSet2.
WEIGHT BY frequency.
CROSSTABS
  /TABLES=Yearofbirth BY visits2015
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ PHI
  /CELLS=COUNT EXPECTED ROW
  /COUNT ROUND CELL.
Crosstabs
Case Processing Summary
Cases
Valid Missing Total
N Percent N Percent N Percent
Yearofbirth * visits2015 226 100.0% 0 0.0% 226 100.0%
Page 1
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APPENDIX H: DNP ORAL DEFENSE PPT 
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